GoodRx Review

GoodRx is a discount card, not a clinic — and that changes everything

Almost every provider we review on Weight Loss Rankings is a telehealth service: you fill out a form, a clinician writes a script, and a pharmacy ships the medication. GoodRx is a different animal. At its core it is the largest prescription-savings platform in the US (NASDAQ: GDRX), and the thing it actually sells is a coupon. You bring a valid GLP-1 prescription, present the GoodRx card or code at the pharmacy counter, and pay a discounted self-pay rate instead of the sticker price. That single distinction shapes everything about who should use it and who should look elsewhere.

The headline numbers are genuinely strong. Brand-name Foundayo (orforglipron) starts at $149 a month at its lowest dose, and the Zepbound KwikPen (tirzepatide) runs a few hundred dollars — both well under what these drugs typically cost without coverage. For context, the category median across providers we track sits around $170, so GoodRx's brand pricing is competitive even against compounded options.

How the pricing actually works

This is manufacturer-direct pricing, not a third-party negotiation. Lilly delivers the discount through GoodRx, which is why the rates are this low on FDA-approved brand product rather than a compounded copy. The number you see is a cash price you pay at the counter — it does not run through insurance and does not count toward a deductible. There is also no membership fee. You are not subscribing to anything; you are using a free discount card.

One honest caveat: the $149 Foundayo figure is the lowest-dose price. GoodRx's own published Foundayo table scales upward as the dose climbs — the higher tablet strengths land at a few hundred dollars a month rather than the teaser rate. That is normal for a dose-scaling drug, but if you titrate up, budget for the higher tier rather than the headline.

What you can and can't get here

• Foundayo (orforglipron) — Lilly's oral GLP-1, brand-name, priced from $149 at the lowest dose
• Zepbound KwikPen (tirzepatide) — brand-name injectable, a self-pay discount well under Lilly's usual cash list
• Brand only — there are no compounded semaglutide or tirzepatide options through GoodRx
• 70,000+ pharmacies — the card is honored at the largest retail network of any GLP-1 channel we cover

The 70,000-pharmacy network is the real differentiator

Most telehealth GLP-1 providers ship from one or two partner pharmacies on their own timeline. GoodRx flips that: because it is a discount card honored at more than 70,000 US pharmacies, you fill at the same counter you already use — your neighborhood chain, the grocery-store pharmacy, wherever is convenient. There is no shipping window to wait on and no single-pharmacy bottleneck. For people who want to walk in, pick up a real FDA-approved brand product the same day, and skip the mail-order model entirely, nothing else we review comes close on reach. It is available in all 50 states for the same reason — it rides on the existing retail pharmacy system rather than a state-by-state telehealth footprint.

You still need a prescriber — but GoodRx can be that too

The catch with any discount card is that it doesn't write prescriptions. You need a clinician to put orforglipron or tirzepatide on a script before the coupon means anything. If you already have that script from your own doctor, GoodRx is purely a savings tool and you're done. If you don't, GoodRx Care — the company's telehealth arm — offers online visits at a modest per-visit fee (a low-to-mid two-figure cost, less for Gold members) and can issue GLP-1 prescriptions itself. That makes GoodRx a rare one-stop: get the script from GoodRx Care, then redeem the GoodRx card at the pharmacy. Just know these are two separate steps, and the visit fee is on top of the medication cost.

Who should choose GoodRx — and who should skip it

Choose GoodRx if you want brand-name, FDA-approved GLP-1 medication at a self-pay price, you value picking up at a local pharmacy, and you either have a prescription or are happy to use GoodRx Care to get one. It is also a smart move if you simply want to price-check: even patients using another provider sometimes pay less by filling brand product with the GoodRx card.

Skip it if you specifically want compounded semaglutide or tirzepatide — GoodRx doesn't offer that, and compounded options are often cheaper per month. Skip it too if you were hoping the cost would apply to your insurance benefits; this is strictly self-pay and won't touch your deductible. And remember the prices can shift as Lilly's coupon program evolves, so confirm the current rate before you commit.

Trust and safety

There are no FDA warnings on file for GoodRx, and there's a structural reason the safety picture is clean: GoodRx isn't compounding anything or operating its own dispensing pharmacy for these drugs. You receive the actual brand-name, FDA-approved product — Lilly's Foundayo and Zepbound — dispensed by licensed retail pharmacies you already know. The discount itself is manufacturer-backed rather than an opaque third-party markup, which is about as transparent as GLP-1 pricing gets. The one thing to verify yourself is the live rate, since coupon pricing updates frequently. You can see how we weigh these factors in our scoring methodology.

Bottom line

GoodRx earns its place by doing one thing better than anyone: getting you genuine brand-name GLP-1 medication at a fair self-pay price, redeemable almost anywhere, with no membership and no mail-order wait. It is the best channel we cover for brand Foundayo and the Zepbound KwikPen if you have a prescription in hand — and with GoodRx Care, it can even supply that. The honest limits are real: no compounded options, no insurance application, dose-scaling that pushes past the $149 headline, and prices that can move with Lilly's program. If brand-name and convenience matter more to you than the absolute lowest compounded price, GoodRx is hard to beat.

For a side-by-side, Yucca Health ($146/month) and DudeMeds ($149/month) are the most comparable options to weigh against GoodRx.